Profiel
Colleen DeSimone worked as the Chief Accounting Officer, VP-Finance & Controller at Syros Pharmaceuticals, Inc. from 2017 to 2018.
Prior to that, she worked as the Secretary & Treasurer at Cedilla Therapeutics, Inc. Ms. DeSimone completed her undergraduate degree at Holy Cross College (Indiana).
Eerdere bekende functies van Colleen DeSimone
| Bedrijven | Functie | Einde |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 09-03-2018 |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Bedrijfssecretaris | - |
Opleiding van Colleen DeSimone
| Holy Cross College (Indiana) | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
